Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

March 25, 2024

Study Completion Date

April 25, 2024

Conditions
Atrial Fibrillation
Interventions
DEVICE

active tVNS

20 Hz, 250ms at a current just below discomfort threshold for one hour twice a day, starting on post-day 0. Stimulation will continue until 5 days post-operatively or discharge.

DEVICE

sham tVNS

Current set a 0 mA, starting on post-op day 0. Stimulation will continue until 5 days post-operatively or discharge.

Trial Locations (2)

73104

University of Oklahoma, Oklahoma City

90095

University of California, Los Angeles, Los Angeles

All Listed Sponsors
collaborator

University of Oklahoma

OTHER

lead

University of California, Los Angeles

OTHER

NCT04514757 - Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib | Biotech Hunter | Biotech Hunter